登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
Sm2O3
化学文摘社编号:
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352303
EC Number:
235-043-6
MDL number:
assay
99.9% trace metals basis
form
powder
reaction suitability
reagent type: catalyst
core: samarium
density
8.35 g/mL at 25 °C (lit.)
SMILES string
O=[Sm]O[Sm]=O
InChI
1S/3O.2Sm
InChI key
PRCWVHVINXAFRG-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under 氧化钐(III)
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
监管及禁止进口产品
此项目有
S F Ahrabi et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 8(3), 193-201 (1999-06-24)
The effect of the neutron activation factors, i.e., admixture of samarium oxide (Sm2O3) and irradiation time, on the physico-chemical properties of the raw materials and the in vitro dissolution and disintegration of hydrophilic and lipophilic suppositories was investigated. It was
Lloyd G Tillman et al.
Journal of pharmaceutical sciences, 97(1), 225-236 (2007-08-28)
Treatment of systemic disease with phosphorothioate antisense oligonucleotides (PS ASOs) has been accomplished using local or parenteral routes of administration to date. This report describes, for the first time, the effective oral delivery of a second generation oligonucleotide where significant
Matthew D Burke et al.
Pharmaceutical research, 24(4), 695-704 (2007-03-21)
To develop a robust radiolabeling technique to enable evaluation of difficult to radiolabel gastric retentive formulations using gamma scintigraphy. The use of a successful radiolabel will allow accurate assessment of the gastric residence time of the formulations. The retention of
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 228672-100G | 04061838781314 |
| 228672-10G | 04061838781321 |